Bank of Montreal’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-42
Closed -$5K 4540
2021
Q1
$5K Sell
42
-174
-81% -$25.2K ﹤0.01% 4652
2020
Q4
$31K Buy
216
+153
+243% +$19.8K ﹤0.01% 4207
2020
Q3
$8K Sell
63
-47
-43% -$5.78K ﹤0.01% 4235
2020
Q2
$24K Buy
+110
New +$41.9K ﹤0.01% 3771
2020
Q1
Sell
-314
Closed -$213K 4513
2019
Q4
$213K Buy
+314
New +$158K ﹤0.01% 3127

Other funds holding NXTC

Bank of Montreal's NXTC Position: Q2 2021 in Review

Bank of Montreal sold out of NextCure (NXTC) in Q2 2021, closing a stake of 42 shares — an estimated $5K sold.

Bank of Montreal first reported a position in NXTC in Q4 2019 and held it in 5 quarters. The position peaked at $213K in Q4 2019. 78 funds tracked by Wall St. Rank hold NXTC as of Q2 2021.

  • Bank of Montreal reported no remaining NextCure position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 42 NextCure shares in Q2 2021, an estimated $5K.
  • Bank of Montreal first reported a position in NextCure in Q4 2019 and held it in 5 quarters.
  • Bank of Montreal's NextCure position peaked at $213K in Q4 2019.
  • 78 funds tracked by Wall St. Rank held NextCure as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.